BioMarin Pharmaceutical
BMRN
50,40 €
Share price
0.15%
Change (1 day)
-35.15%
Change (1 year)
Categories
Revenue for BioMarin Pharmaceutical (BMRN)
Revenue in 2025 (TTM): €2.73 Billion
According to BioMarin Pharmaceutical's latest financial reports the company's current revenue (TTM 
) is €2.55 Billion. In 2024 the company made a revenue of €2.74 Billion an increase over the revenue in the year 2023 that were of €2.18 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BioMarin Pharmaceutical from 1999 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | €2.73 B | -0.1% |
| 2024 | €2.74 B | 25.32% |
| 2023 | €2.18 B | 12% |
| 2022 | €1.95 B | 19.86% |
| 2021 | €1.63 B | 7.78% |
| 2020 | €1.51 B | -0.57% |
| 2019 | €1.52 B | 16.7% |
| 2018 | €1.30 B | 19.06% |
| 2017 | €1.09 B | 3.11% |
| 2016 | €1.06 B | 30.46% |
| 2015 | €0.81 B | 31.85% |
| 2014 | €0.61 B | 55.42% |
| 2013 | €0.39 B | 4.92% |
| 2012 | €0.37 B | 11.38% |
| 2011 | €0.33 B | 20.14% |
| 2010 | €0.28 B | 24.84% |
| 2009 | €0.22 B | 6.85% |
| 2008 | €0.21 B | 154.7% |
| 2007 | €83.26 M | 30.48% |
| 2006 | €63.81 M | 194.51% |
| 2005 | €21.66 M | |
| 2002 | €13.31 M | 13.76% |
| 2001 | €11.7 M | -10.54% |
| 2000 | €13.08 M | 88.63% |
| 1999 | €6.93 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Ultragenyx Pharmaceutical RARE | €0.51 B | -79.98% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | €55.18 M | -97.84% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | €0.22 B | -91.20% | 🇺🇸 USA |
 Sanofi SNY | €41.02 B | 1,506.60% | 🇫🇷 France |
 Amicus Therapeutics
FOLD | €0.47 B | -81.59% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | €0.46 B | -81.88% | 🇺🇸 USA |